As of Jun 19
| +0.04 / +0.82%|
The 2 analysts offering 12-month price forecasts for Sellas Life Sciences Group Inc have a median target of 12.00, with a high estimate of 13.00 and a low estimate of 11.00. The median estimate represents a +143.41% increase from the last price of 4.93.
The current consensus among 2 polled investment analysts is to Buy stock in Sellas Life Sciences Group Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.